Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas (NCT00843375)
🩺 Plain-English Summary (8th-Grade Level)
Colon cancer is the second most common cancer in men and women. It is a disease that can be prevented if it is found early. Colonoscopy is still the best screening tool for colon cancer and the polyps that turn into colon cancer. However, due to a variety of factors, including affordability, time, and age, not all patients are able to be screened. Researchers are working on other options for early detection that are as accurate as colonoscopy. The purpose of this study if to determine if stool or blood can be used to detect colon cancers as early or earlier than colonoscopy. The researchers plan to use these samples to learn about specific proteins (also known as biomarkers) that may indicate colon polyps, colon cancer or an increased risk of developing colon cancer. In order to learn more about preventing and detecting colon and rectal cancer, we are collecting samples from subjects with cancer, adenomas, and colonoscopies who may be at risk for polyps.
Who can join: Review the eligibility criteria below.
Location: Cedars-Sinai Medical Center — Los Angeles, California
Age range: 18 Years
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (13 Sites)
- Cedars-Sinai Medical Center — Los Angeles, California
- Carle Cancer Center — Urbana, Illinois
- Dana Farber Cancer Institute — Boston, Massachusetts
- University of Michigan — Ann Arbor, Michigan
- University of Minnesota — Minneapolis, Minnesota
- NYU Langone Health — New York, New York
- University of North Carolina — Chapel Hill, North Carolina
- Oregon Health and Science University — Portland, Oregon
- Hershey Medical Center — Hershey, Pennsylvania
- M.D. Anderson Cancer Center — Houston, Texas
- University of Washington — Seattle, Washington
- Flinders Medical Center — Adelaide, South Australia
- St. Michael's Hospital — Toronto, Ontario
📞 Contact the Study Coordinator
Phone: (800) 865-1125
Email: CancerAnswerLine@med.umich.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Colonic Neoplasms
- Strategies for Optimizing a Mailed FIT Program in Appalachia — Columbus, Ohio
- Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer — Tucson, Arizona
- Effects of Aerobic Exercise on Skeletal Muscle Remodeling in Colorectal Cancer — Orlando, Florida
- Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer — Oakland, California
Explore by condition: All Colonic Neoplasms clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.